Early detection of overactive bladder to reduce its impact on quality of life

Early Detection of Overactive Bladder and Elimination of Negative Impact on Quality of Life

Not applicable Interventional Institute of Health Information and Statistics of the Czech Republic · NCT07371000

This project tests an online screening tool and telemedicine referral to find overactive bladder in adults who urinate more than seven times a day and connect them with specialists.

Quick facts

PhaseNot applicable
Study typeInterventional
Enrollment1000 (estimated)
Ages18 Years and up
SexAll
SponsorInstitute of Health Information and Statistics of the Czech Republic Government
Locations20 sites (Brno and 19 other locations)
Trial IDNCT07371000 on ClinicalTrials.gov

What this trial studies

Overactive bladder is common in adults but many people do not seek or receive appropriate care. This pilot uses a web and mobile screening tool with validated questionnaires and secure GDPR-compliant data storage to identify people with possible OAB. Participants with positive screening results are offered an in-person exam by a participating gynecologist, urogynaecologist, or urologist who reviews the online data, confirms or rules out the diagnosis, and arranges standard diagnostic tests and treatment. Participation requires online consent and aims to streamline referral pathways from awareness to specialist care.

Who should consider this trial

Good fit: Adults aged 18 or older who experience increased urinary frequency (more than seven voids in 24 hours), with or without nocturia or urge incontinence, are the intended participants.

Not a fit: People already receiving OAB treatment, those with acute urinary problems, suspected alternative causes of symptoms (for example blood in the urine or suspected bladder cancer), or active lower urinary tract infections are unlikely to benefit from this screening pathway.

Why it matters

Potential benefit: If successful, the program could help people with OAB get diagnosed earlier and routed to appropriate treatment, reducing symptoms and improving quality of life.

How similar studies have performed: Digital screening and telemedicine referral programs have shown promise in other conditions and there is emerging work on urinary symptom screening, but this specific pilot implementation is relatively novel.

Eligibility criteria

Show full inclusion / exclusion criteria
Inclusion criteria:

* Signed Consent to Participate in the Project and Consent to the Processing of Personal Data (online and paper format)
* Men and women over 18 years of age with increased urinary frequency (more than 7 times in 24 hours)

Optional inclusion criteria:

\- Nycturia and/or urge incontinence.

Exclusion criteria:

* Unsigned Consent to Participate in the Project and Consent to the Processing of Personal Data.
* Current treatment of OAB, acute problems, suspicion of another disease causing OAB symptoms (haematuria, suspected bladder cancer, etc.)
* Inflammation of the lower urinary tract.

Where this trial is running

Brno and 19 other locations

Study contacts

How to participate

  1. Review the eligibility criteria above with your treating physician.
  2. Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
  3. Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions Overactive BladderOveractive bladderScreeningTelemedicineOnline screening tool
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.